SECUKINUMAB SIGNIFICANTLY IMPROVES ASAS20 RESPONSES VERSUS PLACEBO IN MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS PATIENTS

Author(s):
Emery, P.; Baeten, D.; Sieper, J.; Braun, J.; Heijde, D. van der; McInnes, I.; Laar, J. van; Landewe, R.; Wordsworth, P.; Wollenhaupt, J.; Kellner, H.; Paramarta, J.; Bertolino, A.; Gsteiger, S.; Wright, A.; Hueber, W.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-08-31
Language
English
Is part of
Clinical and Experimental Rheumatology (2012), Vol. 30, no. 4, p. 609-609
hdl
1887/118469